Patents by Inventor Rivka Abulafia-Lapid

Rivka Abulafia-Lapid has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100304483
    Abstract: A method for the preparation of a T cell vaccine for the treatment of immunodeficient HIV-infected patients is described herein, based on the enrichment of autologous CD4-reactive CD8 T cells. Also described is a protocol for the implementation of T cell vaccination in immunodeficient HIV-infected, as well as a method of treatment, based on the T cell vaccine developed herein. Finally, kits for preparing the T cell vaccine as well as for implementing the protocol are also provided.
    Type: Application
    Filed: June 9, 2010
    Publication date: December 2, 2010
    Applicants: YEDA RESEARCH & DEVELOPMENT CO. LTD., HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD.
    Inventors: Rivka Abulafia-Lapid, Henri Atlan, Irun R. Cohen
  • Patent number: 7740855
    Abstract: A method for the preparation of a T cell vaccine for the treatment of immunodeficient HIV-infected patients is described herein, based on the enrichment of autologous CD4-reactive CD8 T cells. Also described is a protocol for the implementation of T cell vaccination in immunodeficient HIV-infected, as well as a method of treatment, based on the T cell vaccine developed herein. Finally, kits for preparing the T cell vaccine as well as for implementing the protocol are also provided.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: June 22, 2010
    Assignees: Yeda Research & Development Co. Ltd, Hadasit Medical Research Services and Dev. Ltd
    Inventors: Rivka Abulafia-Lapid, Henri Atlan, Irun R. Cohen
  • Publication number: 20070122877
    Abstract: A method for the preparation of a T cell vaccine for the treatment of immunodeficient HIV-infected patients is described herein, based on the enrichment of autologous CD4-reactive CD8 T cells. Also described is a protocol for the implementation of T cell vaccination in immunodeficient HIV-infected, as well as a method of treatment, based on the T cell vaccine developed herein. Finally, kits for preparing the T cell vaccine as well as for implementing the protocol are also provided.
    Type: Application
    Filed: November 30, 2005
    Publication date: May 31, 2007
    Inventors: Rivka Abulafia-Lapid, Henri Atlan, Irun Cohen